Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Foster, J. K. Albrecht, M. A. Savage, G. Lautenschlager, N. T. Ellis, K. A. Maruff, P. Szoeke, C. Taddei, K. Martins, R. Masters, C. L. and Ames, D. 2013. Lack of reliable evidence for a distinctive  4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study. Brain, Vol. 136, Issue. 7, p. 2201.


    ×

The APOE gene and cognitive function in non-demented and Alzheimer's disease patients

  • Antony Payton (a1)
  • DOI: http://dx.doi.org/10.1017/S0959259809990268
  • Published online: 19 October 2009
Abstract
Summary

This review discusses the role that the APOE gene plays in cognitive dysfunction both in demented and non-demented elderly people. The increasing problem of cognitive impairment in developed countries makes finding new and effective treatments a research priority. Understanding the biological basis of this impairment is therefore paramount. APOE has received much attention in the field of cognitive genetics due to it being a major susceptibility gene for Alzheimer's disease, which itself is characterized by a rapid and irreversible loss in memory function. Over the past 14 years this has generated a considerable number of publications that have produced conflicting findings, making it difficult for the reader to interpret whether the APOE gene regulates cognition or not. This review attempts to summarize the mass of information on this gene in relation to cognition, by weighting the pros and cons of the methodologies used, and offers suggestions for future study designs.

Copyright
Corresponding author
Address for correspondence: Dr Antony Payton, Centre for Integrated Genomic Medical Research, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PT, UK. Email: tony.payton@manchester.ac.uk
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

1A Comas-Herrera , R Wittenberg , L Pickard , M Knapp . Cognitive impairment in older people: future demand for long-term care services and the associated costs. Int J Geriatr Psychiatry 2007; 22: 1037–45.

3C Spearman . ‘General intelligence’ objectively determined and measured. Am J Psychol 1904; 15: 201–93.

6IJ Deary . Human intelligence differences: a recent history. Trends Cogn Sci 2001; 5: 127–30.

7JJ Jones , P van Schaik , P Witts . A factor analysis of the Wechsler Adult Intelligence Scale 3rd Edition (WAIS-III) in a low IQ sample. Br J Clin Psychol 2006; 45: 145–52.

8B Devlin , M Daniels , K Roeder . The heritability of IQ. Nature 1997; 388: 468–71.

9TJ Jr Bouchard , M McGue . Genetic and environmental influences on human psychological differences. J Neurobiol 2003; 54: 445.

10L Qi , YA Cho . Gene–environment interaction and obesity. Nutr Rev 2008; 66: 684–94.

11TE Thorgeirsson , F Geller , P Sulem A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452: 638–42.

12JH Kim , PE Elwood , MI Asher . Diet and asthma: looking back, moving forward. Respir Res 2009; 10: 49.

13A Caspi , B Williams , J Kim-Cohen Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proc Natl Acad Sci USA 2007; 104: 18860–65.

14FT Wang , H Hu , J Schwartz Modifying effects of the HFE polymorphisms on the association between lead burden and cognitive decline. Environ Health Perspect 2007; 115: 1210–15.

15E Morales , J Sunyer , F Castro-Giner Influence of glutathione S-transferase polymorphisms on cognitive functioning effects induced by p, p’-DDT among preschoolers. Environ Health Perspect 2008; 116: 1581–15.

16W Johnson , SE Harris , JM Starr , LJ Whalley , IJ Deary . PPARG Pro12Ala genotype and risk of cognitive decline in elders? Maybe with diabetes. Neurosci Lett 2008; 434: 5055.

17M. Ridley Nature via Nurture. Harper Collins, New York, 2003.

18GE McClearn , B Johansson , S Berg , NL Pedersen , F Ahern , SA Petrill , R Plomin . Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science 1997; 276: 1560–63.

19FM Spinath , A Ronald , N Harlaar , TS Price , R Plomin . Phenotypic g early in life: on the etiology of general cognitive ability in a large population sample of twin children aged 2–4 years. Intelligence 2003; 31: 195210.

20F Giubilei , E Medda , C Fagnani Heritability of neurocognitive functioning in the elderly: evidence from an Italian twin study. Age Ageing 2008; 37: 640–46.

21JS Peper , RM Brouwer , DI Boomsma , RS Kahn , HE Hulshoff . Genetic influences on human brain structure: a review of brain imaging studies in twins. Hum Brain Map 2007; 28: 464–73.

22D Posthuma , WF Baaré , HE Hulshoff Pol , RS Kahn , DI Boomsma , EJ De Geus . Genetic correlations between brain volumes and the WAIS-III dimensions of verbal comprehension, working memory, perceptual organization, and processing speed. Twin Res 2003; 6: 131–39.

25JP Godbout , RW Johnson . Age and neuroinflammation: a lifetime of psychoneuroimmune consequences. Neurol Clin 2006; 24: 521–38.

26DH Mauch , K Nägler , S Schumacher , C Göritz , EC Müller , A Otto , FW Pfrieger . CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001; 294: 1354–57.

27RW Mahley . E Apolipoprotein : cholesterol transport protein with expanding role in cell biology. Science 1988; 240: 622–30.

28BJ Small , CB Rosnick , L Fratiglioni , L Bäckman . Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004; 19: 592600.

29L Bertram , RE Tanzi . Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nature Rev Neurosci 2008; 9: 768–78.

31J Raber , Y Huang , JW Ashford . ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging 2004; 25: 641–50.

32AS Khachaturian , CD Corcoran , LS Mayer , PP Zandi , JC Breitner . Apolipoprotein E ɛ4 count affects age at onset of Alzheimer's disease, but not lifetime susceptibility: the Cache County Study. Arch Gen Psychiatry 2004; 61: 518–24.

33G Bu . Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 2009; 10: 333–44.

34BP Nathan , S Bellosta , DA Sanan , KH Weisgraber , RW Mahley , RE Pitas . Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 1994; 264: 850–52.

36B Teter , PT Xu , JR Gilbert , AD Roses , D Galasko , GM Cole . Defective neuronal sprouting by human apolipoprotein E4 is a gain-of negative function. J Neurosci Res 2002; 68: 331–36.

37KC Kutner , DM Erlanger , J Tsai , B Jordan , NR Relkin . Lower cognitive performance of older football players possessing apolipoprotein E ɛ4. Neurosurgery 2000; 47: 651–57.

38BD Jordan , NR Relkin , LD Ravdin , AR Jacobs , A Bennett , S Gandy . Apolipoprotein E ɛ4 associated with chronic traumatic brain injury in boxing. JAMA 1997; 278: 136–40.

39WJ Strittmatter , KH Weisgraber , DY Huang Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 8098–102.

40GW Rebeck , JS Reiter , DK Strickland , BT Hyman . Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions. Neuron 1993; 11: 575–80.

41DA Bennett , RS Wilson , JA Schneider Apolipoprotein E ɛ4 allele, AD pathology, and the clinical expression of Alzheimer's disease. Neurology 2003; 60: 246–52.

42T Polvikoski , R Sulkava , M Haltia Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 1995; 333: 1242–47.

43A Drzezga , T Grimmer , G Henriksen Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer's disease. Neurology 2009; 72: 1487–94.

44MA Marques , M Tolar , JA Harmony , KA Crutcher . A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. Neuroreport 1996; 7: 2529–32.

46Y Huang , XQ Liu , T Wyss-Coray , WJ Brecht , DA Sanan , RW Mahley . Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA 2001; 98: 8838–43.

47D Eddins , RC Klein , JL Yakel , ED Levin . Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment. Brain Res Bull 2009; 79: 111–15.

48EH Corder , AM Saunders , WJ Strittmatter Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921–23.

49S Bookheimer , A Burggren . APOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging. Ann Rev Clin Psychol 2009; 5: 343–62.

51JC Breitner , BW Wyse , JC Anthony APOE-ɛ4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology 1999; 53: 321–31.

52LA Farrer , LA Cupples , JL Haines Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer's disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997; 278: 1349–56.

54IJ Deary , MC Whiteman , A Pattie Cognitive change and the APOE ɛ4 allele. Nature 2002; 418: 932.

57IJ Deary , MC Whiteman , JM Starr , LJ Whalley , HC Fox . The impact of childhood intelligence on later life: following up the Scottish mental Surveys of 1932 and 1947. J Pers Soc Psychol 2004; 86: 130–47.

58SG Mueller , N Schuff , S Raptentsetsang , J Elman , MW Weiner . Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T. Neuroimage 2008; 42: 4248.

59G Bartzokis , PH Lu , DH Geschwind Apolipoprotein E affects both myelin breakdown and cognition: implications for age-related trajectories of decline into dementia. Biol Psychiatry 2007; 62: 1380–87.

60AC Burggren , MM Zeineh , AD Ekstrom , MN Braskie , PM Thompson , GW Small , SY Bookheimer . Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage 2008; 41: 1177–83.

61TN Tombaugh , NJ McIntyre . The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992; 40: 922–35.

62P Rabbitt , C Lowe . Patterns of cognitive ageing. Psychol Res 2000; 63: 308–16.

63D Finkel , CA Reynolds , JJ McArdle , NL Pedersen . Age changes in processing speed as a leading indicator of cognitive aging. Psychol Aging 2007; 22: 558–68.

64P Rabbitt , P Diggle , F Holland , L McInnes . Practice and drop-out effects during a 17-year longitudinal study of cognitive aging. J Gerontol B Psychol Sci Soc Sci 2004; 59: 8497.

65J Savitz , M Solms , R Ramesar . Apolipoprotein E variants and cognition in healthy individuals: a critical opinion. Brain Res Rev 2006; 51: 125–35.

66CJ Packard , RG Westendorp , DJ Stott Prospective study of pravastatin in the elderly at risk group. Association between apolipoprotein E4 and cognitive decline in elderly adults. J Am Geriatr Soc 2007; 55: 1777–85.

67JW Cargin , P Maruff , A Collie , R Shafiq-Antonacci , C Masters . Decline in verbal memory in non-demented older adults. J Clin Exp Neuropsychol 2007; 29: 706–18.

68LA Tupler , KR Krishnan , DL Greenberg Predicting memory decline in normal elderly: genetics, MRI, and cognitive reserve. Neurobiol Aging 2007; 28: 1644–56.

69H Christensen , PJ Batterham , AJ Mackinnon The association of APOE genotype and cognitive decline in interaction with risk factors in a 65–69 year old community sample. BMC Geriatr 2008; 8: 14.

72RJ Caselli , AC Dueck , D Osborne Longitudinal modeling of age-related memory decline and the APOE ɛ4 effect. N Engl J Med 2009; 361: 255–63.

73P van Vliet , AM Oleksik , SP Mooijaart , AJ de Craen , RG Westendorp . APOE genotype modulates the effect of serum calcium levels on cognitive function in old age. Neurology 2009; 72: 821–28.

74Z Nagy , MM Esiri , KA Jobst , C Johnston , S Litchfield , E Sim , AD Smith . Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease. Neuroscience 1995; 69: 757–61.

75TG Ohm , M Kirca , J Bohl , H Scharnagl , W Gross , W März . Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 1995; 66: 583–87.

76N Cherbuin , LS Leach , H Christensen , KJ Anstey . Neuroimaging and APOE genotype: a systematic qualitative review. Dement Geriatr Cogn Disord 2007; 24: 348–62.

77C Marra , A Bizzarro , A Daniele Apolipoprotein E ɛ4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients. Dement Geriatr Cogn Disord 2004; 18: 125–31.

78LC Lam , NL Tang , SL Ma , VW Lui , AS Chan , PY Leung , HF Chiu . Apolipoprotein ɛ-4 allele and the two-year progression of cognitive function in Chinese subjects with late-onset Alzheimer's disease. Am J Alzheimers Dis Other Demen 2006; 21: 9299.

79S Cosentino , N Scarmeas , E Helzner , MM Glymour , J Brandt , M Albert , D Blacker , Y Stern . APOE ɛ4 allele predicts faster cognitive decline in mild Alzheimer's disease. Neurology 2008; 70: 1842–49.

81JC Morris , S Edland , C Clark The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology 1993; 43: 2457–65.

83BL Plassman , JC Breitner . Apolipoprotein E and cognitive decline in Alzheimer's disease. Neurology 1996; 47: 317–20.

85H Basun , M Grut , B Winblad , L Lannfelt . Apolipoprotein ɛ4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 1995; 183: 3234.

86T Asada , T Kariya , Z Yamagata , T Kinoshita , A Asaka . ApoE ɛ4 allele and cognitive decline in patients with Alzheimer's disease. Neurology 1996; 47: 603.

87C Holmes , R Levy , DM McLoughlin , JF Powell , S Lovestone . Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996; 61: 580–83.

88G Dal Forno , DX Rasmusson , J Brandt , KA Carson , R Brookmeyer , J Troncoso , CH Kawas . Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Arch Neurol 1996; 53: 345–50.

89A Kurz , R Egensperger , M Haupt , N Lautenschlager , B Romero , MB Graeber , U Müller . Apolipoprotein E ɛ4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology 1996; 47: 440–43.

90JH Growdon , JJ Locascio , S Corkin , T Gomez-Isla , BT Hyman . Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology 1996; 47: 444–48.

92C Jonker , B Schmand , J Lindeboom , LM Havekes , LJ Launer . Association between apolipoprotein E ɛ4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia. Arch Neurol 1998; 55: 1065–69.

93M Lehtovirta , J Kuikka , S Helisalmi Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism. J Neurol Neurosurg Psychiatry 1998; 64: 742–46.

94MR Farlow , PA Cyrus , A Nadel , DK Lahiri , A Brashear , B Gulanski . Metrifonate treatment of AD: influence of APOE genotype. Neurology 1999; 53: 2010–16.

95AJ Slooter , JJ Houwing-Duistermaat , F van Harskamp Apolipoprotein E genotype and progression of Alzheimer's disease: the Rotterdam Study. J Neurol 1999; 246: 304–8.

96J Aerssens , P Raeymaekers , S Lilienfeld , H Geerts , F Konings , W Parys . APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease. Dement Geriatr Cogn Disord 2001; 12: 6977.

97E Mori , K Lee , M Yasuda , M Hashimoto , H Kazui , N Hirono , M Matsui . Accelerated hippocampal atrophy in Alzheimer's disease with apolipoprotein E ɛ4 allele. Ann Neurol 2002; 51: 209–14.

98T Kleiman , K Zdanys , B Black Apolipoprotein E ɛ4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis. Dement Geriatr Cogn Disord 2006; 22: 7382.

100L Bracco , C Piccini , M Baccini Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype. Dement Geriatr Cogn Disord 2007; 24: 483–91.

101S Craft , L Teri , SD Edland Accelerated decline in apolipoprotein E-ɛ4 homozygotes with Alzheimer's disease. Neurology 1998; 51: 149–53.

102M Kanai , M Shizuka , K Urakami , E Matsubara , Y Harigaya , K Okamoto , M Shoji . Apolipoprotein E4 accelerates dementia and increases cerebrospinal fluid tau levels in Alzheimer's disease. Neurosci Lett 1999; 267: 6568.

103N Hirono , M Hashimoto , M Yasuda , H Kazui , E Mori . Accelerated memory decline in Alzheimer's disease with apolipoprotein ɛ4 allele. J Neuropsychiatry Clin Neurosci 2003; 15: 354–58.

104CA Martins , A Oulhaj , CA de Jager , JH Williams . APOE alleles predict the rate of cognitive decline in Alzheimer's disease: a non-linear model. Neurology 2005; 65: 1888–93.

105GB Frisoni , S Govoni , C Geroldi , A Bianchetti , L Calabresi , G Franceschini , M Trabucchi . Gene dose of the ɛ4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol 1995; 37: 596604.

106Y Stern , J Brandt , M Albert , DM Jacobs , X Liu , K Bell , K Marder , M Sano , S Albert , C Del-Castillo Castenada , F Bylsma , B Tycko , R Mayeux . The absence of an apolipoprotein ɛ4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol 1997; 41: 615–20.

107BD Hoyt , PJ Massman , C Schatschneider , N Cooke , RS Doody . Individual growth curve analysis of APOE ɛ4-associated cognitive decline in Alzheimer's disease. Arch Neurol 2005; 62: 454–59.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Reviews in Clinical Gerontology
  • ISSN: 0959-2598
  • EISSN: 1469-9036
  • URL: /core/journals/reviews-in-clinical-gerontology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords: